Literature DB >> 25517465

hPSC-derived maturing GABAergic interneurons ameliorate seizures and abnormal behavior in epileptic mice.

Miles Cunningham1, Jun-Hyeong Cho2, Amanda Leung3, George Savvidis3, Sandra Ahn3, Minho Moon3, Paula K J Lee3, Jason J Han4, Nima Azimi1, Kwang-Soo Kim3, Vadim Y Bolshakov2, Sangmi Chung5.   

Abstract

Seizure disorders debilitate more than 65,000,000 people worldwide, with temporal lobe epilepsy (TLE) being the most common form. Previous studies have shown that transplantation of GABA-releasing cells results in suppression of seizures in epileptic mice. Derivation of interneurons from human pluripotent stem cells (hPSCs) has been reported, pointing to clinical translation of quality-controlled human cell sources that can enhance inhibitory drive and restore host circuitry. In this study, we demonstrate that hPSC-derived maturing GABAergic interneurons (mGINs) migrate extensively and integrate into dysfunctional circuitry of the epileptic mouse brain. Using optogenetic approaches, we find that grafted mGINs generate inhibitory postsynaptic responses in host hippocampal neurons. Importantly, even before acquiring full electrophysiological maturation, grafted neurons were capable of suppressing seizures and ameliorating behavioral abnormalities such as cognitive deficits, aggressiveness, and hyperactivity. These results provide support for the potential of hPSC-derived mGIN for restorative cell therapy for epilepsy.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25517465      PMCID: PMC4270101          DOI: 10.1016/j.stem.2014.10.006

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  39 in total

1.  Epilepsy in the world today: medical point of view.

Authors:  Jerome Engel
Journal:  Epilepsia       Date:  2002       Impact factor: 5.864

2.  Postnatal differentiation of basket cells from slow to fast signaling devices.

Authors:  Daniel Doischer; Jonas Aurel Hosp; Yuchio Yanagawa; Kunihiko Obata; Peter Jonas; Imre Vida; Marlene Bartos
Journal:  J Neurosci       Date:  2008-11-26       Impact factor: 6.167

Review 3.  Issues related to symptomatic and disease-modifying treatments affecting cognitive and neuropsychiatric comorbidities of epilepsy.

Authors:  Amy R Brooks-Kayal; Kevin G Bath; Anne T Berg; Aristea S Galanopoulou; Gregory L Holmes; Frances E Jensen; Andres M Kanner; Terence J O'Brien; Vicky H Whittemore; Melodie R Winawer; Manisha Patel; Helen E Scharfman
Journal:  Epilepsia       Date:  2013-08       Impact factor: 5.864

4.  Side effects of antiepileptics--a review.

Authors:  Kulbir S Walia; Elizabeth A Khan; Dong H Ko; Shariq S Raza; Yasin N Khan
Journal:  Pain Pract       Date:  2004-09       Impact factor: 3.183

Review 5.  Epilepsy in 2013: progress across the spectrum of epilepsy research.

Authors:  Frances E Jensen
Journal:  Nat Rev Neurol       Date:  2014-01-14       Impact factor: 42.937

6.  Dendritic but not somatic GABAergic inhibition is decreased in experimental epilepsy.

Authors:  R Cossart; C Dinocourt; J C Hirsch; A Merchan-Perez; J De Felipe; Y Ben-Ari; M Esclapez; C Bernard
Journal:  Nat Neurosci       Date:  2001-01       Impact factor: 24.884

7.  Cortical plasticity induced by inhibitory neuron transplantation.

Authors:  Derek G Southwell; Robert C Froemke; Arturo Alvarez-Buylla; Michael P Stryker; Sunil P Gandhi
Journal:  Science       Date:  2010-02-26       Impact factor: 47.728

8.  Status epilepticus causes long-term NMDA receptor-dependent behavioral changes and cognitive deficits.

Authors:  A C Rice; C L Floyd; B G Lyeth; R J Hamm; R J DeLorenzo
Journal:  Epilepsia       Date:  1998-11       Impact factor: 5.864

9.  ILAE Commission Report. Mesial temporal lobe epilepsy with hippocampal sclerosis.

Authors:  Heinz-Gregor Wieser
Journal:  Epilepsia       Date:  2004-06       Impact factor: 5.864

Review 10.  Interneurons from embryonic development to cell-based therapy.

Authors:  Derek G Southwell; Cory R Nicholas; Allan I Basbaum; Michael P Stryker; Arnold R Kriegstein; John L Rubenstein; Arturo Alvarez-Buylla
Journal:  Science       Date:  2014-04-11       Impact factor: 47.728

View more
  94 in total

1.  Immature Interneurons Create a Lasting Impression.

Authors:  Janice R Naegele; Laura B Grabel; Gloster Aaron
Journal:  Epilepsy Curr       Date:  2015 May-Jun       Impact factor: 7.500

Review 2.  Concise Review: Exciting Cells: Modeling Genetic Epilepsies with Patient-Derived Induced Pluripotent Stem Cells.

Authors:  Andrew M Tidball; Jack M Parent
Journal:  Stem Cells       Date:  2015-09-15       Impact factor: 6.277

Review 3.  Potential of GABA-ergic cell therapy for schizophrenia, neuropathic pain, and Alzheimer's and Parkinson's diseases.

Authors:  Ashok K Shetty; Adrian Bates
Journal:  Brain Res       Date:  2015-09-28       Impact factor: 3.252

Review 4.  Using Patient-Derived Induced Pluripotent Stem Cells to Model and Treat Epilepsies.

Authors:  Xixi Du; Jack M Parent
Journal:  Curr Neurol Neurosci Rep       Date:  2015-10       Impact factor: 5.081

Review 5.  Chronobiology of limbic seizures: Potential mechanisms and prospects of chronotherapy for mesial temporal lobe epilepsy.

Authors:  Daniel Leite Góes Gitai; Tiago Gomes de Andrade; Ygor Daniel Ramos Dos Santos; Sahithi Attaluri; Ashok K Shetty
Journal:  Neurosci Biobehav Rev       Date:  2019-01-07       Impact factor: 8.989

6.  The telomerase inhibitor AZT enhances differentiation and prevents overgrowth of human pluripotent stem cell-derived neural progenitors.

Authors:  Yao Hu; Kai-Heng Fang; Lu-Ping Shen; Shi-Ying Cao; Fang Yuan; Yuwen Su; Min Xu; Yufeng Pan; Yaoyu Chen; Yan Liu
Journal:  J Biol Chem       Date:  2018-04-08       Impact factor: 5.157

7.  An in vivo model of functional and vascularized human brain organoids.

Authors:  Abed AlFatah Mansour; J Tiago Gonçalves; Cooper W Bloyd; Hao Li; Sarah Fernandes; Daphne Quang; Stephen Johnston; Sarah L Parylak; Xin Jin; Fred H Gage
Journal:  Nat Biotechnol       Date:  2018-04-16       Impact factor: 54.908

8.  Single-injection ex ovo transplantation method for broad spinal cord engraftment of human pluripotent stem cell-derived motor neurons.

Authors:  Maria C Estevez-Silva; Akshitha Sreeram; Stephanie Cuskey; Nikolai Fedorchak; Nisha Iyer; Randolph S Ashton
Journal:  J Neurosci Methods       Date:  2018-02-03       Impact factor: 2.390

9.  In Vivo Chimeric Alzheimer's Disease Modeling of Apolipoprotein E4 Toxicity in Human Neurons.

Authors:  Ramsey Najm; Kelly A Zalocusky; Misha Zilberter; Seo Yeon Yoon; Yanxia Hao; Nicole Koutsodendris; Maxine Nelson; Antara Rao; Alice Taubes; Emily A Jones; Yadong Huang
Journal:  Cell Rep       Date:  2020-07-28       Impact factor: 9.423

10.  Nav1.1-Overexpressing Interneuron Transplants Restore Brain Rhythms and Cognition in a Mouse Model of Alzheimer's Disease.

Authors:  Magdalena Martinez-Losa; Tara E Tracy; Keran Ma; Laure Verret; Alexandra Clemente-Perez; Abdullah S Khan; Inma Cobos; Kaitlyn Ho; Li Gan; Lennart Mucke; Manuel Alvarez-Dolado; Jorge J Palop
Journal:  Neuron       Date:  2018-03-15       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.